West Pharmaceutical Services, Inc.
WSTLast close · Oct 16, 2026384.02+1.00 (+0.26%)
Market cap$27.0B
Of the 85 managers this site tracks, 3 held West Pharmaceutical Services (WST) at the end of Q2 2026, their latest 13Fs. The largest position by value was Gates's, $159.6M; Bridgewater's ($3.7M) and Hillman Capital's ($2.6M) follow. No Schedule 13D or 13G is on file for WST from the activists and large holders the site follows.
Superinvestors holding WST
| Manager | Firm | Quarter | Shares | Value |
|---|---|---|---|---|
| Gates | Gates Foundation Trust | Q2 2026 | 444,500 | $159.6M |
| Bridgewater | Bridgewater Associates, LP | Q2 2026 | 10,429 | $3.7M |
| Hillman Capital | Hillman Capital Management, Inc. | Q2 2026 | 7,106 | $2.6M |
13D/13G are SEC beneficial-ownership disclosures, triggered only above 5%; a 13F is a quarterly snapshot filed up to 45 days after quarter end. Superinvestor names link to their full portfolios under Investors.